Possible heart failure exacerbation associated with rosiglitazone: case report and literature review. - Wikidata - wikimedia - TriplyDB

Possible heart failure exacerbation associated with rosiglitazone: case report and literature review.

Possible heart failure exacerbation associated with rosiglitazone: case report and literature review.

http://www.wikidata.org/entity/Q35186548

about

Recent findings concerning thiazolidinediones in the treatment of diabetes.Investigational PPAR-gamma agonists for the treatment of Type 2 diabetes.PPARgamma agonists: safety issues in heart failure.Cardiovascular risk of rosiglitazone: another perspective.Discovery and development of selective PPAR gamma modulators as safe and effective antidiabetic agents.The comorbidity conundrum: a focus on the role of noncardiovascular chronic conditions in the heart failure patient.Latest research and development trends in non-insulin anti-diabetics.The importance of synthetic drugs for type 2 diabetes drug discovery.The effect of substituted thiophene and benzothiophene derivates on PPARgamma expression and glucose metabolism.Thiazolidinediones and congestive heart failure-exacerbation or new onset of left ventricular dysfunction?

P2860

Q36407304-33B589CD-51AD-4AE2-8108-5442983EDCB3 Q36512559-2E4C9AFC-82D0-4900-924A-D4D41B1F270E Q36857537-45A2D3D2-383E-4C8C-81A0-11A9645451C0 Q37322689-89786060-3FA8-4C8D-9FBD-C6B8100F843E Q37724195-71C70EFB-8B85-46EC-84BF-78F5F119A7B1 Q37993441-4E8004D9-545D-4774-B2C2-DD8047DE2143 Q38080471-D97C4955-A422-408B-8AEC-F9058FE4B929 Q38139508-DECF62BD-23A5-4E43-B2C6-EA0854871DE2 Q43296443-FEBC0EE2-3F54-4FB3-95B5-08A031528B2B Q57243283-1114143C-1408-4572-9B54-55AE7BF3B163

P2860

Possible heart failure exacerbation associated with rosiglitazone: case report and literature review.

http://www.wikidata.org/entity/Q35186548

description

2003 nî lūn-bûn

@nan

2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Possible heart failure exacerb ...... report and literature review.

@ast

Possible heart failure exacerb ...... report and literature review.

@en

type

label

Possible heart failure exacerb ...... report and literature review.

@ast

Possible heart failure exacerb ...... report and literature review.

@en

prefLabel

Possible heart failure exacerb ...... report and literature review.

@ast

Possible heart failure exacerb ...... report and literature review.

@en

P1433

Q35186548-D58B9784-56E7-4368-B745-50789F8A92C5

P1476

Q35186548-7BDB7364-19E3-467A-880E-D6FB89BE7BE1

P2093

Q35186548-51F40133-BDE0-4BB3-97CF-A1695E23AF4F

Q35186548-52B6B23A-2794-4926-B6A3-ED008FF46076

Q35186548-B1A1F4C0-042E-451A-AE01-D97DAD180F06

P2860

Q35186548-003546B5-9A5C-4A38-98BD-3CA6E6B1082D

Q35186548-0C556732-E1C6-4E33-9FF6-CD6F1909DAA3

Q35186548-0C57E912-74AB-4473-B948-B170BF9E08F3

Q35186548-1D4CBAEA-3457-4B3C-A1AB-37CDA9D72C91

Q35186548-2E3019D2-DCA8-4AFC-89A2-28997620094F

Q35186548-33BB192A-B05A-44D8-9275-88F8FA1F1EE2

Q35186548-362C1D5F-25D6-4019-B172-416ABEB101DC

Q35186548-3CCD267E-0664-45E5-BB07-6959C4E36D91

Q35186548-3FDC1312-89FE-496B-A340-BD58A7EC6039

Q35186548-5D619B24-5C13-4196-BF7D-E90C0E262357

P304

Q35186548-639D3D85-85A0-4092-9A53-B824DE1AE250

P31

Q35186548-3FE6001E-D119-4E05-9CE0-879CD0B6FB30

P356

Q35186548-23827CD6-A49C-4D14-AA68-194068024E69

P407

Q35186548-88DC2BF7-1F6B-47AF-B558-7F5146D4D27E

P433

Q35186548-EE5D62FF-8E7D-4E30-A0D3-FAF43F9A9F42

P478

Q35186548-CB8FB57E-E5D8-4E25-8141-FBF6F93F9B5C

P577

Q35186548-E306D607-2AC4-4D28-A88A-9F9F29B80969

P698

Q35186548-24F9497B-A733-4069-A8A1-E27BC80F1632

P356

PHCO.23.7.945.32721

P1433

Pharmacotherapy

P1476

Possible heart failure exacerb ...... report and literature review.

@en

P2093

J Mark Ruscin

http://www.w3.org/2001/XMLSchema#string

Robert Lee Page

http://www.w3.org/2001/XMLSchema#string

Wendolyn S Gozansky

http://www.w3.org/2001/XMLSchema#string

P2860

A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

A method for estimating the probability of adverse drug reactions

The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years.

Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial--the Losartan Heart Failure Survival Study ELITE II.

Prognostic impact of diabetes mellitus in patients with heart failure according to the etiology of left ventricular systolic dysfunction.

Diabetes mellitus and congestive heart failure. Further knowledge needed.

The role of tumor necrosis factor in the pathophysiology of heart failure.

Potential role of TNF-alpha in the pathogenesis of insulin resistance and type 2 diabetes.

Cardiomyopathy and heart failure in diabetes.

P304

945-954

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1592/PHCO.23.7.945.32721

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

23

http://www.w3.org/2001/XMLSchema#string

P577

2003-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12885108

http://www.w3.org/2001/XMLSchema#string